Literature DB >> 25686663

Detergent sclerosants are deactivated and consumed by circulating blood cells.

D E Connor1, O Cooley-Andrade2, W X Goh2, D D F Ma3, K Parsi4.   

Abstract

OBJECTIVE: To investigate the deactivating effects of circulating blood cells on the lytic activity of detergent sclerosants.
METHODS: Samples of whole blood (WB), platelet-rich plasma (PRP), and isolated leukocytes were incubated with various concentrations of sodium tetradecyl sulfate (STS) or polidocanol (POL) and added to human umbilical vein endothelial cells (HUVECs), which were then counted using a fluorescent plate reader. Full blood counting was performed using a hematology analyzer. Platelet lysis and microparticle formation was assessed using lactadherin binding in flow cytometry.
RESULTS: Detergent sclerosant activity was decreased in WB when compared with plasma and saline controls. The sclerosant lytic activity on endothelial cells was increased 23-fold for STS and 59-fold for POL in saline controls compared with WB. At high concentrations, sclerosants lysed erythrocytes, leukocytes, and platelets. Platelets were more sensitive to the lytic activity of sclerosants than other cell types. Neutrophils were the most susceptible of all leukocytes to the lytic activity of sclerosants. The presence of erythrocytes and leukocytes in samples decreased the lytic activity of sclerosants. Sclerosants at all concentrations induced erythrocyte-derived microparticle formation.
CONCLUSIONS: Detergent sclerosants are consumed and deactivated by circulating blood cells. This deactivating effect is above and beyond the neutralizing effects of plasma proteins and contributes to the overall neutralizing effect of blood. Different blood cell types exhibited varying levels of vulnerability to the lytic activity of sclerosants with platelets being the most and erythrocytes the least vulnerable (platelets > leukocytes > erythrocytes).
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell lysis; Cell-derived microparticles; Detergent sclerosants; Neutralization

Mesh:

Substances:

Year:  2015        PMID: 25686663     DOI: 10.1016/j.ejvs.2014.12.029

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

Review 1.  [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

2.  In vitro and ex vivo evaluation of the biological performance of sclerosing foams.

Authors:  Elisabetta Bottaro; Jemma A J Paterson; Luciano Quercia; Xunli Zhang; Martyn Hill; Venisha A Patel; Stephen A Jones; Andrew L Lewis; Timothy M Millar; Dario Carugo
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

3.  Red cell distribution width and erythrocyte osmotic stability in type 2 diabetes mellitus.

Authors:  Maria Aparecida Knychala; Mario da Silva Garrote-Filho; Breno Batista da Silva; Samantha Neves de Oliveira; Sarah Yasminy Luz; Manuela Ortega Marques Rodrigues; Nilson Penha-Silva
Journal:  J Cell Mol Med       Date:  2021-02-16       Impact factor: 5.310

4.  Efficacy and safety of polidocanol in the treatment of varicose veins of lower extremities: A protocol for systematic review and meta-analysis.

Authors:  Nan Li; Junhai Li; Mei Huang; Xiujun Zhang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

Review 5.  Sclerotherapy in the treatment of varicose veins : S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP.

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-12       Impact factor: 0.751

6.  The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

Authors:  Dario Carugo; Dyan N Ankrett; Vincent O'Byrne; David D I Wright; Andrew L Lewis; Martyn Hill; Xunli Zhang
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

7.  Gradient acoustic focusing of sub-micron particles for separation of bacteria from blood lysate.

Authors:  David Van Assche; Elisabeth Reithuber; Wei Qiu; Thomas Laurell; Birgitta Henriques-Normark; Peter Mellroth; Pelle Ohlsson; Per Augustsson
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.